The use of historical priors to improve the efficiency of phase II clinical trials with time-to-event endpoints
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The use of historical priors to improve the efficiency of phase II clinical trials with time-to-event endpoints ; volume:14 ; number:1 ; day:29 ; month:11 ; year:2013 ; pages:1 ; date:11.2013
Trials ; 14, Heft 1 (29.11.2013), 1, 11.2013
- Creator
-
Jackson, Richard
- Contributor
-
Cox, Trevor
Tudur-Smith, Catrin
SpringerLink (Online service)
- DOI
-
10.1186/1745-6215-14-S1-P53
- URN
-
urn:nbn:de:1111-2016050233770
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jackson, Richard
- Cox, Trevor
- Tudur-Smith, Catrin
- SpringerLink (Online service)
Other Objects (12)
Composite time-to-event endpoints in clinical and epidemiologic trials : evaluation of alternative analysis methods
Patient recruitment strategies for adaptive enrichment designs with time-to-event endpoints
Imputation of Missing Data for Time-to-Event Endpoints Using Retrieved Dropouts
Mixed response and time-to-event endpoints for multistage single-arm phase II design
Statistical modeling strategies for linking multiple molecular sources to time-to-event endpoints : = Statistische Modellbildungsstrategien zur Verknüpfung multipler molekularer Quellen unter Berücksichtigung von Time-to-Event Endpunkten
Using the geometric average hazard ratio in sample size calculation for time-to-event data with composite endpoints
Evaluating quality of hospital care using time-to-event endpoints based on patient follow-up data
Confirmatory adaptive group sequential designs for single‐arm phase II studies with multiple time‐to‐event endpoints
Physical function endpoints in cancer cachexia clinical trials: systematic review 1 of the cachexia endpoints series
Improving the analysis of composite endpoints in rare disease trials
Assessing the impact of selection bias on test decisions in trials with a time-to-event outcome
Endpoints for clinical trials in retinal diseases
Composite time-to-event endpoints in clinical and epidemiologic trials : evaluation of alternative analysis methods
Patient recruitment strategies for adaptive enrichment designs with time-to-event endpoints
Imputation of Missing Data for Time-to-Event Endpoints Using Retrieved Dropouts
Mixed response and time-to-event endpoints for multistage single-arm phase II design
Statistical modeling strategies for linking multiple molecular sources to time-to-event endpoints : = Statistische Modellbildungsstrategien zur Verknüpfung multipler molekularer Quellen unter Berücksichtigung von Time-to-Event Endpunkten
Using the geometric average hazard ratio in sample size calculation for time-to-event data with composite endpoints
Evaluating quality of hospital care using time-to-event endpoints based on patient follow-up data
Confirmatory adaptive group sequential designs for single‐arm phase II studies with multiple time‐to‐event endpoints
Physical function endpoints in cancer cachexia clinical trials: systematic review 1 of the cachexia endpoints series
Improving the analysis of composite endpoints in rare disease trials
Assessing the impact of selection bias on test decisions in trials with a time-to-event outcome
Endpoints for clinical trials in retinal diseases
Composite time-to-event endpoints in clinical and epidemiologic trials : evaluation of alternative analysis methods
Patient recruitment strategies for adaptive enrichment designs with time-to-event endpoints
Imputation of Missing Data for Time-to-Event Endpoints Using Retrieved Dropouts
Mixed response and time-to-event endpoints for multistage single-arm phase II design
Statistical modeling strategies for linking multiple molecular sources to time-to-event endpoints : = Statistische Modellbildungsstrategien zur Verknüpfung multipler molekularer Quellen unter Berücksichtigung von Time-to-Event Endpunkten
Using the geometric average hazard ratio in sample size calculation for time-to-event data with composite endpoints
Evaluating quality of hospital care using time-to-event endpoints based on patient follow-up data
Confirmatory adaptive group sequential designs for single‐arm phase II studies with multiple time‐to‐event endpoints
Physical function endpoints in cancer cachexia clinical trials: systematic review 1 of the cachexia endpoints series
Improving the analysis of composite endpoints in rare disease trials
Assessing the impact of selection bias on test decisions in trials with a time-to-event outcome